Literature DB >> 11732560

Living with arthritis--what is important?

K M McPherson1, P Brander, W J Taylor, H K McNaughton.   

Abstract

PURPOSE: Demonstrating the effectiveness of health care interventions requires valid measurement of the impact of those interventions. However, outlining precisely what constitutes a 'good outcome' in the field of rehabilitation is no easy task and tends to rely on models proposed by 'experts' rather than people with the disabling conditions. This paper describes a study exploring outcomes that those people with a disabling condition (arthritis) consider important.
METHOD: A qualitative study, interviewing 10 women with rheumatoid arthritis was carried out. The narratives were explored for categories and themes that encapsulated the perspective of the participants.
RESULTS: A range of categories was identified and collated into five themes (personal/intrinsic factors, external/extrinsic factors, future issues, perceptions of normality and taking charge).
CONCLUSIONS: The research supports in part, but also challenges more commonly used models of understanding the important consequences of disease and disability. The findings of the study may assist health professionals to reflect on current practice and reconsider processes used, and outcomes aimed for, in light of what patients/clients consider important.

Entities:  

Mesh:

Year:  2001        PMID: 11732560     DOI: 10.1080/09638280110049919

Source DB:  PubMed          Journal:  Disabil Rehabil        ISSN: 0963-8288            Impact factor:   3.033


  8 in total

1.  Ethnicity, equity, and quality: lessons from New Zealand.

Authors:  K M McPherson; M Harwood; H K McNaughton
Journal:  BMJ       Date:  2003-08-23

2.  Experiences of gout-related disability from the patients' perspective: a mixed methods study.

Authors:  Peter M ten Klooster; Harald E Vonkeman; Martijn A H Oude Voshaar; Christina Bode; Mart A F J van de Laar
Journal:  Clin Rheumatol       Date:  2014-08       Impact factor: 2.980

3.  What outcomes from pharmacologic treatments are important to people with rheumatoid arthritis? Creating the basis of a patient core set.

Authors:  T Sanderson; M Morris; M Calnan; P Richards; S Hewlett
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-05       Impact factor: 4.794

4.  Patient perspective of measuring treatment efficacy: the rheumatoid arthritis patient priorities for pharmacologic interventions outcomes.

Authors:  T Sanderson; M Morris; M Calnan; P Richards; S Hewlett
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-05       Impact factor: 4.794

Review 5.  [Treat-to-target from the patient perspective].

Authors:  E Gromnica-Ihle; M Rink
Journal:  Z Rheumatol       Date:  2011-10       Impact factor: 1.372

6.  Construct validity of the interview time trade-off and computer time trade-off in patients with rheumatoid arthritis: a cross-sectional observational pilot study.

Authors:  Laurien Buitinga; Louise Ma Braakman-Jansen; Erik Taal; Mart Afj van de Laar
Journal:  BMC Musculoskelet Disord       Date:  2012-06-25       Impact factor: 2.362

7.  Factors promoting health-related quality of life in people with rheumatic diseases: a 12 month longitudinal study.

Authors:  Susann Arvidsson; Barbro Arvidsson; Bengt Fridlund; Stefan Bergman
Journal:  BMC Musculoskelet Disord       Date:  2011-05-20       Impact factor: 2.362

8.  Patient experiences, attitudes and expectations towards receiving information about anti-TNF medication--"It could give me two heads and I'd still try it!".

Authors:  Paul Arkell; Sarah Ryan; Ann Brownfield; Anthony Cadwgan; Jon Packham
Journal:  BMC Musculoskelet Disord       Date:  2013-05-10       Impact factor: 2.362

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.